XML 49 R5.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Balance at beginning of period at Dec. 31, 2017 $ 245,583   $ 209,603 $ 35,980
Balance at beginning of period (in shares) at Dec. 31, 2017   41,641    
Exercise of common stock options 1,212   1,212  
Exercise of common stock options (in shares)   415    
Stock-based compensation 7,427   7,427  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (361)   (361)  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (in shares)   13    
Net income 9,070     9,070
Balance at end of period at Mar. 31, 2018 262,931   217,881 45,050
Balance at end of period (in shares) at Mar. 31, 2018   42,069    
Balance at beginning of period at Dec. 31, 2017 245,583   209,603 35,980
Balance at beginning of period (in shares) at Dec. 31, 2017   41,641    
Net income 48,705      
Balance at end of period at Sep. 30, 2018 337,014   252,329 84,685
Balance at end of period (in shares) at Sep. 30, 2018   43,185    
Balance at beginning of period at Mar. 31, 2018 262,931   217,881 45,050
Balance at beginning of period (in shares) at Mar. 31, 2018   42,069    
Exercise of common stock options 1,997   1,997  
Exercise of common stock options (in shares)   365    
Stock-based compensation 9,872   9,872  
Issuance of common stock under employee stock purchase plan 7,014   7,014  
Issuance of common stock under employee stock purchase plan (in shares)   392    
Restricted stock award grants, net of forfeitures and shares withheld for taxes (183)   (183)  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (in shares)   28    
Net income 19,343     19,343
Balance at end of period at Jun. 30, 2018 300,974   236,581 64,393
Balance at end of period (in shares) at Jun. 30, 2018   42,854    
Exercise of common stock options 3,956   3,956  
Exercise of common stock options (in shares)   330    
Stock-based compensation 11,851   11,851  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (59)   (59)  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (in shares)   1    
Net income 20,292     20,292
Balance at end of period at Sep. 30, 2018 337,014   252,329 84,685
Balance at end of period (in shares) at Sep. 30, 2018   43,185    
Balance at beginning of period at Dec. 31, 2018 394,567   270,447 124,120
Balance at beginning of period (in shares) at Dec. 31, 2018   43,864    
Exercise of common stock options 9,502   9,502  
Exercise of common stock options (in shares)   592    
Stock-based compensation 16,324   16,324  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (1,146)   (1,146)  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (in shares)   23    
Net income 10,151     10,151
Balance at end of period at Mar. 31, 2019 429,398   295,127 134,271
Balance at end of period (in shares) at Mar. 31, 2019   44,479    
Balance at beginning of period at Dec. 31, 2018 394,567   $ 270,447 $ 124,120
Balance at beginning of period (in shares) at Dec. 31, 2018   43,864    
Net income 57,373      
Balance at end of period at Sep. 30, 2019 $ 535,392      
Balance at end of period (in shares) at Sep. 30, 2019 535,392 45,121 353,899 181,493
Balance at beginning of period at Mar. 31, 2019 $ 429,398   $ 295,127 $ 134,271
Balance at beginning of period (in shares) at Mar. 31, 2019   44,479    
Exercise of common stock options 7,473   7,473  
Exercise of common stock options (in shares)   284    
Stock-based compensation 21,390   21,390  
Issuance of common stock under employee stock purchase plan 8,648   8,648  
Issuance of common stock under employee stock purchase plan (in shares)   153    
Restricted stock award grants, net of forfeitures and shares withheld for taxes (2,488)   (2,488)  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (in shares)   7    
Net income 27,800     27,800
Balance at end of period at Jun. 30, 2019 492,221   330,150 162,071
Balance at end of period (in shares) at Jun. 30, 2019   44,923    
Exercise of common stock options 4,936   4,936  
Exercise of common stock options (in shares)   196    
Stock-based compensation 19,923   19,923  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (1,110)   $ (1,110)  
Restricted stock award grants, net of forfeitures and shares withheld for taxes (in shares)   2    
Net income 19,422     $ 19,422
Balance at end of period at Sep. 30, 2019 $ 535,392      
Balance at end of period (in shares) at Sep. 30, 2019 535,392 45,121 353,899 181,493